Indomethacin has proven effective in closing the patent ductus arteriosus (PDA) in most low birth weight (LBW) neonates with this disorder. Early reopening of the ductus is a problem and often leads to the need for surgery. Prolonged use of indomethacin for several days has been suggested as a means
✦ LIBER ✦
Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus
✍ Scribed by Hannsjörg W. Seyberth; Wolfgang Rascher; Renate Hackenthal; Lutz Wille
- Book ID
- 119460462
- Publisher
- Elsevier Science
- Year
- 1983
- Tongue
- English
- Weight
- 519 KB
- Volume
- 103
- Category
- Article
- ISSN
- 1097-6833
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Effects of prolonged versus acute indome
✍
P. G. Rhodes; M. G. Ferguson; N. S. Reddy; J. A. Joransen; J. Gibson
📂
Article
📅
1988
🏛
Springer
🌐
English
⚖ 400 KB
Introduction of plasma indomethacin leve
✍
H. W. Seyberth; G. Knapp; D. Wolf; H. E. Ulmer
📂
Article
📅
1983
🏛
Springer
🌐
English
⚖ 676 KB
First results are described of individually tailored indomethacin dose rates employing on-line drug level monitoring for pharmacologically induced ductal constriction in very low birth weight infants with symptomatic patent ductus arteriosus (sPDA). In addition prolonged indomethacin therapy was int